Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03495908 · ClinicalTrials.gov registry record · NA
Regular Insulin vs Rapid Insulin Delivered by V-Go
A NA study, sponsored by East Coast Institute for Research.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
NCT03495908 is a NA study that has completed, run by East Coast Institute for Research. The registered enrollment target is 136 participants.
The verdict
NCT03495908, a NA study, has completed, sponsored by East Coast Institute for Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
Study Summary
The purpose of the study is to collect data about how well U-100 Regular Human Insulin can be used in the V-Go Insulin Delivery Device compared to U-100 Rapid Acting Insulin in the V-Go Insulin Delivery Device. The data collected will be used to see how much subjects' blood sugar levels change over time after they switch from using U-100 Rapid Acting Insulin to U-100 Regular Human Insulin within their V-Go Insulin Delivery Device.
Interventions
- DEVICE VGo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2018-04-09 |
| Est. Completion | 2019-08-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03495908
The ClinicalTrials.gov registry entry for NCT03495908 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is East Coast Institute for Research, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VGo is the first listed.
NCT03495908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03495908 about?
NCT03495908 is a clinical study titled "Regular Insulin vs Rapid Insulin Delivered by V-Go". The purpose of the study is to collect data about how well U-100 Regular Human Insulin can be used in the V-Go Insulin Delivery Device compared to U-100 Rapid Acting Insulin in the V-Go Insulin Delivery Device. The data collected will be used to see how much subjects' blood sugar levels change over ...
What is the current status of trial NCT03495908?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2018-04-09. Estimated completion is 2019-08-12.
What interventions are being tested in trial NCT03495908?
The interventions under investigation include: VGo (DEVICE).
Who is sponsoring clinical trial NCT03495908?
This trial is sponsored by East Coast Institute for Research, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.